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Summary 
Invariant  chain  (Ii)  associates  with  newly  synthesized  class  II  molecules  in  the  endoplasmic 
reticulum  (ElK), an interaction that has been shown to interfere with peptide binding to class II 
molecules. The class II-associated invariant chain peptide (CLIP) region (residues 81-104)  of Ii 
is believed to mediate this inhibition  by engaging the binding domain  of class  II hke an anti- 
genic peptide.  Together,  these findings have given rise to a model in which  CLIP association 
with the class II groove acts to prevent inappropriate presentation ofpeptides imported into the 
El<  for  association  with  major  histocompatibility  complex  class  I  molecules.  However,  the 
properties  of class II molecules  synthesized by cells lacking coexpressed  Ii are at least superfi- 
cially inconsistent with this paradigm in that they do not show clear evidence ofpeptide acqui- 
sition.  At  the  same  time,  we  have  previously  shown  the  shortest  form  of Ii still  containing 
CLIP to play an essential role in regulation  of early class  II molecule assembly and transport in 
the  secretory pathway.  Using covalent peptide  technology,  we now show  that  occupancy  of 
the class  II binding site in the ElK regulates class II trafficking to the Golgi complex, an event 
that is the locus of the major defect in cells ofli-deficient mice. These data argue that CLIP oc- 
cupies the class II binding site, not to prevent interaction with short peptides meant for class  I, 
but rather to maintain  the  structural  integrity  of class II molecules  that are labile without  en- 
gaged binding regions, and that would also associate with intact proteins in the ElK if left unoc- 
cupied.  By these means, CLIP occupancy of the class  II binding site promotes effective export 
of useful class II molecules for endocytic peptlde acquisition. 
I 
nvariant  chain  (Ii)  regulates  many  of the  properties  of 
MHC  class II molecules (1), including peptide binding m 
vitro (2, 3).  This latter observation led to the view that the 
class II-associated invariant chain peptide  (CLIP) region of Ii 
(residues  81-104)  occupies  the  class  II binding  site  (4)  to 
inhibit presentation of the endogenous peptides that normally 
associate  with  MHC  class  I  molecules  in  the  endoplasmic 
renculum  (ElK)  (5, 6). Newly synthesized class II molecules 
from cells lacking Ii, however, do not show clear evidence 
of the peptide binding that is predicted by this model.  Class 
II  proteins  synthesized  without  Ii  undergo  inefficient  or/[3 
chain assembly in some haplotypes  (7-9),  fail to achieve an 
SDS-stable  conformation,  transport  poorly from El<  to the 
Golgi complex (7-10),  aggregate (11), and do not show tight 
association with elutable peptide ligands (12). 
Intriguingly,  CLIP makes a  critical  contribution  to pre- 
venting  all  of these  defects  in  early  class  II  assembly  and 
transport,  especially class  II ElK-to-Golgi complex traffick- 
ing (13).  Unoccupied  class  II molecules  are known  to rap- 
idly denature  or misfold (14-16),  and they can bind to in- 
tact proteins (17,  18), events that would be likely to inhibit 
effective postsynthetic  transport  of class  II molecules.  To- 
gether,  these observations led us to consider that any inhi- 
bition of El< peptide binding by CLIP interaction with the 
class II groove might be incidental  to a required role in es- 
tablishing and preserving a functional  class  II conformation 
that promotes efficient transport  (1,  13,  19).  In agreement 
with this hypothesis, we report here that class  II occupancy 
in  the  ElK by either  short  antigenic  peptides  or by  CLIP 
alone  fully replaces  the  secretory  pathway  functions  of Ii, 
emphasizing  the  concept  that  class  II activity  depends  on 
controlled engagement of the binding region at all times af- 
ter synthesis (19). 
Materials and Methods 
cDNA Expression Constructs.  The cDNA constructs  coding for 
the wild-type (x or ]3 chain ofA  k and A t' in plasmid CDM8 and 
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pcEXV-3 have been described previously (13, 20). The Ec152-68: 
A[3  b construct m plasrmd pHbAPlk-l-neo was kindly provided by 
Drs. J. Kappler and P. Marrack (HHMI, Denver, CO)  (21).  The 
constructs  hen  egg  lysozyme  (HEL)116-129:A[3  k,  HEL46-61: 
AI3  k, HEL46-61mut:A[3  k, and mclip:A[3  k in plasmid pCDL-SRo~ 
(22) were generated in the following manner. The HEL46-61:A[3  k 
construct was  prepared  first  and served as  a  cloning vector for 
making the other A[3  k constructs. Two partially overlapping oligos 
were synthesized with the forward primer sequence 5'-ACTGAG- 
GGCGGA_AACTCCGGCCCAGGAGGCCGTAACACCGAT- 
GGGAGTACCGACTACGGAATCCTACAGATCAACAGCA- 
GGCCG-3' and the backward primer sequence 5'-CTGGTGC- 
ACGAAATGCCTTTCGGATCCACCTCCACCTGGTGCT- 
GAGCCACCGCCTCCAGGCCCTGACGGCCTGCTGTTG- 
ATCTG-3'.  The  partially  overlapping  primers  were  extended 
using Taq polymerase to produce a double stranded DNA frag- 
ment that codes for HEL peptide 46-61 and a linker region. The 
DNA fragment was then inserted in between codons 4 and 5 of[31 
domain of mature A[3  k. Two noncompatlble sill sites were placed 
flanking the peptide coding region, allowing the enclosed peptide- 
coding sequence to  be  replaced by other pepnde-encoding se- 
quences. To make the HELl16-129:, HEL46-61mut:, and CLIP: 
A[3  k constructs, dsDNAs coding for the corresponding peptides were 
made by extending two partially overlapping oligos using PCR 
and  then  splicing  them  into  the  HEL46-61:Ai3k-pCDL-SRa 
plasmld by using the sill sites. As a result, the HEL46-61 was re- 
placed with HELl16-129,  HEL46-61mut,  or mouse CLIP  (see 
Fig. 1 for amino acid sequences). The HEL46-61 mut sequence was 
derived from HEL46-61 and contains six amino acid substitutions: 
D52 to R, Y53 to A, L56 to G, Q57 to A, 58I to K, and 61R to 
G.  These  residues are  either A k or TCR  contact residues  (23). 
The  sequences  were  confirmed  using an  automated  DNA  se- 
quencer. 
Transfection.  COS  7.2 cells  were  transiently transfected with 
cDNA  constructs using a  DEAE-dextran method  as previously 
described (24) and incubated 48 h in DMEM/10% FCS. Rat ba- 
sophil leukemia  (RBL)  cells  were  stably transfected using elec- 
troporation followed by selection in G418  (Geneticm; GIBCO 
BRL, Gaithersburg, MD).  G418-resistant cells were analyzed by 
flow  cytofluorometry  7-10  d  after  transfection.  Positive  cells 
were  cloned by limiting dilution. The clones with intermediate 
expression level were used in the experiments. 
Metabolic Labeling, Immunoprecipitation, and SDS-PAGE.  Meta- 
bohc labehng, immunoprecipitatlons, and SDS-PAGE were car- 
ned out as described elsewhere (14, 25) with some modifications. 
The class II molecules were precipitated with the mAb M5/114 
(26),  the mouse mAb Y-Ae (specific  for the A  b molecule bound 
to the Eoe52-68 peptide [27]),  or the mAb 10.2.16  (28)  (specific 
for A[3k), all previously bound to  protein G-Sepharose  or pro- 
tem-A Sepharose beads. Where samples were examined for SDS- 
stable,  compact dimers,  half of the  precipitate was  eluted using 
sample buffer containing 2% SDS and 5% 2-ME without heating: 
the other half was boiled in sample buffer (14,  15).  Both eluates 
were then analyzed using 10% polyacrylamlde gels. For analysis of 
N-linked glycan status,  the precipitate was eluted with 2% SDS in 
PBS by boiling for 5 rain. The eluate was &luted 10-fold with ly- 
sis buffer and then reprecipitated with a rabbit antiserum raised 
against a  peptide  corresponding to  a  sequence from  the  tall of 
class II cx chains (25).  The reprecipltate was diwded into two parts 
and incubated m  50  mM sodium citrate buffer,  pH  5.5,  in the 
presence or absence of 15  mU of endoglycosidase H  (endo H; 
Boehrlnger Mannheim Corp., Indianapolis, IN) at 37°C for 16 h 
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Figure  1.  Structure  of h  and class I1 wild-type  and variant proteins. 
The protein structures of fulMength mouse Ia (p31), the truncated mem- 
brane-anchored form Ii19-107 contammg CLIP, wild-type A[3  b and A[3  k, 
pepnde-tethered  A[3  b and A[3  k, and wild-type Ao~  b and A~x  k are illustrated 
&agrammatlcally. 
(29).  The  treated  samples were  then eluted using normal SDS- 
PAGE sample buffer with heating and analyzed on 10% gels. 
Results 
Rapid  Binding of Tethered Peptides to  the  Class II Binding 
Groove.  To  examine whether groove binding could sub- 
stitute  for  Ii  in promoting  class  II  ER  to  Golgi  complex 
trafficking,  it  was  necessary  to  attain  near  stoichiometric 
occupancy of newly synthesized class II dimers with CLIP 
or alternative ligands. We first determined if this could be 
accomplished  by  biosynthetic  attachment  of peptide  se- 
quences to the NHe  terminus of the  [3 chain (30)  (Fig.  1). 
Earlier studies with such engineered [3 chains showed high 
binding site occupancy of those class II molecules reaching 
the cell surface (21) but did not examine whether the pep- 
tide  was  inserted  in  the  ER  or  later  after  movement  to 
other intracellular organelles, nor the efficiency of transport 
of these molecules. A  protein containing the Ec152-68 pep- 
tide  associated  with  the  A[3  b  chain  [Eot52-68:A[3  b]  was 
used, because binding of free Eot52-68 peptide to A 6 pro- 
duces class II dimers that remain intact during SDS-PAGE, 
and the mAb Y-Ae recognizes A b dimers only when they 
have this peptide in the binding groove (27), providing two 
measures of effective  occupancy.  In transfected  COS  cells 
metabolically labeled for  40  rain,  a  substantial amount of 
Y-Ae-precipitable material was present that ran as a  stable 
&mer in SDS-PAGE  (Fig.  2  A), indicating that these class 
II molecules had  the  tethered Eci peptide  sequence prop- 
erly bound in the  groove.  The  endo H  sensitivity of the 
N-linked  glycans  on  the  o~  chains  of  these  molecules 
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Figure 2.  ER occupancy of the class II binding site by tethered  pep- 
tides promotes  rapid  transport  of these  loaded  molecules  through  the 
Golga complex and submtutes for the function of h. (A) A[3  b chains teth- 
ered to Eoe52-68 form SDS-stable dimers with wild-type  Ac~  u m trans- 
fected  COS cells. Class II darners were  precipitated  from pulse-labeled, 
transfected COS cells and subjected to SDS-PAGE w]thout prior sample 
heating (left lane) or wath sample heating (right lane). C, compact, SDS-sta- 
ble dlmers.  (B) Binding of tethered  E0~52-68 to the binding groove  of 
class II occurs before transport to the Golgi complex. Class II darners  from 
transfected COS cells were labeled for 40 rain, and then isolated ~x chains 
were examined to determine  the extent of N-linked carbohydrate matu- 
rattan as a measure of transport through the Golgl complex.  (C) Wild- 
type A~x  b and A[3  b coexpressed without h  in COS cells show only poor 
movement from the ElL to the Golga complex  Class II dlmers were pre- 
cipitated from pulse-labeled or pulse-labeled and chased transfected COS 
cells coexpressmg  wald-type Ac~  b and A[3  b chains, and the relsolated ~x chain 
showed that peptide binding involved molecules resident 
in  the  ElK  (Fig.  2  B).  Thus,  this  approach  provided  a 
method  for  evaluating whether  rapid  binding site  occu- 
pancy mimicking class II association with Ii via CLIP pro- 
motes efficient ElK-to-Golgi complex trafficking. 
Antigenic  Peptide  Binding  Replaces  CLIP/Ii  Function  in 
Class II ER-to-Golgi  Complex  Transport.  COS  cells  were 
then  transfected  with  constructs  encoding wild-type  A[3  b 
and Ael  b chains alone, these wild-type chains together with 
the  minimal Ii segment  (Ii19-107)  able  to  provide  CLIP- 
dependent  enhancement  of secretory  pathway  trafficking 
(13), or the Eix52-68:A[3  b chain plus Ao& Cells were pulse 
labeled or pulsed and chased  for 4  h,  and then the  class  II 
proteins  were  analyzed for  SDS  stability and  the  endo  H 
sensitivity of el chain glycans.  In agreement with previous 
studies  (8,  9),  none of the wild-type class II molecules ex- 
pressed with or without Ii19-107 had the SDS-stable phe- 
notype associated with fight peptide binding (data not shown). 
All  pulse-labeled  samples  showed  only  endo  H-sensitive 
carbohydrates  on  the  ot  chains,  consistent with  their resi- 
dence in the EK  (Fig. 2,  C-E).  After 4  h  of chase,  only a 
minor fraction  (<20%)  of the  dimers produced  in the  ab- 
sence of Ii contained Ao~ chains with N-linked glycans re- 
sistant to endo H  digestion (Fig. 2  C). Coexpression of the 
19-107 fragment of Ii markedly enhanced the transport  of 
these wild-type class II dimers, with 70% of the Aoe chains 
showing evidence of Golgi passage  after 4  h  (Fig. 2  D).  In 
contrast to the wild-type A s molecules, 75% of class II mol- 
ecules  contaimng  the  Eel  peptide-linked  [3  chains  were 
SDS  stable after pulse labeling (data not shown)  and strik- 
ingly, the  same  proportion showed  evidence of passage  to 
the Golgi after 4  h  (Fig. 2  E). This agrees with the data ob- 
tained using the Y-Ae antibody, which showed  that  all of 
the loaded molecules detected with this reagent transported 
efficiently (Fig. 2 A). Thus, a tethered peptide was as effec- 
tive in promoting class II transport as was CLIP-containing Ii. 
MHC  class  II  o~  chains have  two  N-linked glycans.  In 
normal  hematopoietic  cells,  one  glycan  is  typically  fully 
processed  to  the  mature  form, whereas  a  variable  amount 
of the second becomes endo H  resistant. The differences in 
the  pattern  of endo  H-resistant  forms  for  the  ot  chain in 
Fig.  2,  C-E,  indicate  that  the  interaction of class  II  with 
large  ligands such  as  Ii or perhaps  large  proteins,  as  com- 
pared  to  short  groove-filling peptides,  alters  the  ratio  of 
such glycan processing. 
To  determine if this  capacity  of binding site  occupancy 
to  enhance  transport  was  a  general  property  of  class  II 
was examined for endo H sensitivity of the N-hnked glycans. (D) Wild- 
type  A~  b and  A[3  b  coexpressed  with  a  CLIP-containing membrane- 
anchored fragment of h in COS cells show efficient movement from the 
ER to  the  Golgl complex.  Cells coexpressmg wild-type  A~x  b and A[3  b 
chains together  with the h19-107  fragment were treated and the class II 
proteins  were  analyzed as m  C.  (E)  Wild-type Ac~  b coexpressed with 
E~x52-68:A[3  b form class II darners  occupied with the tethered pepnde that 
show as efficient transport from the ElL to the Golgi complex as wild- 
type A  b dlmers bound to CLIP-containing Ia, Cells coexpressmg EIx52- 
68:A[3  b and wild-type Aot  b were treated and the class II proteins were an- 
alyzed as m C. 
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Figure 3.  Effective  pepnde occupancy of the binding region of newly 
synthesized class II A  k molecules ~s reqmred to promote efiqoent transport 
from the Et< through the Golga complex  RBL transfectants expressing 
the ]n&cated wdd-type or peptlde-assoclated class II proteins were pulse 
labeled or pulse labeled and chased Class II &mers were lmmunopreclpl- 
tated and rather analyzed  for SDS stability or for the endo H sensitivity  of 
the tx chain N-linked glycans. 
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Figure  4.  The  CLIP sequence tethered  to  A  k molecules replaces h 
function for class II ER-to-Golgl complex transport without  reducing 
formation of SDS-stable &mers lkBL cells were cotransfected with con- 
structs encoding wild-type  Atx  k and A[~  k tethered  to  the  sequence of 
mouse CLIP  Cells  were labeled and class II proteins were analyzed as m 
Figs. 1-3. 
dimers,  we  conducted  similar experiments  using  tethered 
peptides associated with  the A~  k chain and expressed in a 
distinct cell type. A k has a very low affinity for CLIP  (31), 
in contrast to A b its assembly is not noticeably affected by h 
(9), and it is less dependent on h  for transport than A b (32). 
Wild-type A k chains, as well as A~  k chains attached to HEL 
peptides  46-61  or  116-129  coexpressed  with  wild-type 
Ao~  k,  were  analyzed as described above for A b.  Wild-type 
A k formed SDS-unstable dimers in the ER that showed no 
Golgi complex trafficking during the pulse-labeling period, 
whereas  65%  of the  molecules had  endo  H-resistant gly- 
cans  after  4  h  of chase  (Fig.  3).  In  contrast,  A k  dimers 
bound  to  the  HEL  46-61  or  116-129  sequences  were 
largely SDS stable in the ER,  and after only 40 min, ~20% 
of the  molecules already showed  evidence  of Golgi com- 
plex transit. After a  4  h  chase,  essentially all the molecules 
had endo  H-resistant glycans (Fig. 3).  Thus,  the ability of 
covalently attached peptide sequences  to  promote  class  II 
transport appears to be a general property of these ligands. 
The spacer between the tethered peptide and the begin- 
ning  of the  authentic  A~  chain  lies  near  one  of the  Ac~ 
chain carbohydrate attachment sites. Because N-linked gly- 
cans  are  involved in  calnexin binding  (33),  the  transport- 
promoting properties of these constructs might have related 
not  to  binding  site  occupancy,  but  to  sterlc  interference 
with calnexin binding and loss of ER retention.  To exam- 
ine  this  issue,  multiple residues in  the  46-61  pepude,  in- 
cluding  those  involved  in  binding  to  A k,  were  mutated. 
Class  II  molecules  tethered  to  this  nonbinding  sequence 
failed  to  show  enhanced  trafficking  from  ER  to  Golgi 
complex, although the [3 chains still had the peptide linker 
region attached (Fig. 3). This provides strong evidence that 
trafficking is dependent on binding site occupancy. 
CLIP Alone  Replaces Ii  Function in  Class II ER-to-Golgi 
Complex Transport.  In all these  cases  using tethered anti- 
genic peptides, most  class II molecules rapidly folded into 
compact,  SDS-stable  dimers,  and  transport  was  quantita- 
tively  related  to  such  stable  dimer  formation,  h-class  It 
complexes, however,  do not have this SDS-stable confor- 
mation  (14).  To  examine whether the  SDS-stable confor- 
mation was essential to transport, and to test whether CLIP 
alone  could replace  li function,  a  construct  encoding  the 
core region of mouse CLIP tethered to AI3  k was used. Co- 
expression of this chain with As k did not lead to  genera- 
tion  of SDS-stable dimers  (Fig.  4),  consistent  with  other 
studies showing that many ligands do not produce SDS-sta- 
ble forms when  they associate with the binding domain of 
class  II  (29,  34,  35).  Nevertheless,  the  CLiP-containing 
complex  still  transported  more  efficiently than  wild-type 
A k dimers,  indicating that  the  CLIP  segment possesses by 
itself all the properties necessary for enhancing class II ER.- 
to-Golgi complex transport, and further,  that it can medi- 
ate this effect without inducing the  SDS-stable conforma- 
tion of class II. 
Discussion 
Although the class II chaperone function of h  is well ap- 
preciated,  it  is  still widely  held  that  Ii  interacts  with  the 
class II binding groove via CLIP to inhibit presentation of 
endogenous  peptides  intended  for  class  I  binding  in  the 
ER.  Given  the  present  data,  the  absence  of SDS-stable 
dimers in the Elq, of the  cells of Ii-deficient mice and  the 
failure of SDS-unstable class II dimers in such cells to trans- 
port effectively clearly indicate that most class II molecules 
do  not  associate  tightly  with  peptide  ligands  m  that  or- 
ganelle even when  Ii is totally absent (8).  Our observations 
thus  support  the  alternative  hypothesis  that  the  primary 
secretory pathway functions of Ii, and of CLIP in particu- 
lar, are to stabilize properly folded class II dimers and facili- 
tate their secretory pathway trafficking in a functional state 
(1,  18,  19). 
All tested  short  hgands  capable  of effective  interaction 
with the  class II binding region promoted secretory path- 
way transport of class II.  This was  true  both  for antlgemc 
peptides  that  led  to  class  II  folding  into  a  highly  stable 
dlmer conformation  and  for  CLIP  itself, which  facilitated 
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ble  state  characteristic of class  II-Ii complexes  (14).  This 
peptide-mediated class  II  transport  represents  one  of the 
few  examples  of ligand-dependent trafficking of receptor 
proteins in the secretory pathway (36). The ease of manip- 
ulating the  involved peptide together with  knowledge  of 
the detailed structure of class II molecules make this an in- 
triguing model for studies relating protein folding to  exit 
from the ER. 
It thus seems that class II molecules have  evolved to be 
highly dependent on ligand binding for their proper intra- 
cellular movement  and  functional  survival under  physio- 
logic conditions, as originally observed for class I molecules 
(37).  Some form of binding site engagement must be pro- 
vided shortly after class H biosynthesis to prevent loss of ac- 
tivity during transport to endocytic locations, and CLIP as- 
sociation with the groove fulfills this requirement. Concerted 
exchange  of CLIP for antigenic peptides via the action of 
DM (38-40) also conforms to the idea that the class II binding 
site  cannot  be  left  unoccupied  other  than  transiently,  as 
does inactivation 9 f surface-expressed class II molecules af- 
ter loss of peptide, unless a new ligand is quickly acquired 
(14-16).  Thus,  for its optimal functioning, a class II mole- 
cule must  have  its binding site properly chaperoned  at all 
stages of its post-synthetic lifetime. 
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